Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: Utility and pitfalls
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood and adolescence. Despite intergroup clinical trials conducted in Europe and North America, outcomes for high risk patients with this disease have not significantly improved in the last several decades, and survival of metasta...
Main Authors: | Ashley R.P. Hinson, Rosanne eJones, Lisa E.S. Crose, Brian eBelyea, Frederic G. Barr, Corinne M. Linardic |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00183/full |
Similar Items
-
Tumor suppressive functions of WNT5A in rhabdomyosarcoma
by: Bauer, J., et al.
Published: (2022) -
Embryonal Rhabdomyosarcoma of the Mandible
by: Rodante A. Roldan, et al.
Published: (2005-11-01) -
DCX and CRABP2 are candidate genes for differential diagnosis between pre‐chemotherapy embryonic and alveolar rhabdomyosarcoma in pediatric patients
by: Nian Sun, et al.
Published: (2021-06-01) -
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
by: Narendra Bharathy, et al.
Published: (2019-05-01) -
Clinical Characteristics and Treatment Outcome of Pediatric Rhabdomyosarcoma; Retrospective Review
by: Zunaira Shaukat, et al.
Published: (2021-05-01)